Endothelin induces potent microvascular constriction
Open Access
- 1 December 1988
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 95 (4) , 1005-1007
- https://doi.org/10.1111/j.1476-5381.1988.tb11731.x
Abstract
Endothelin is a recently discovered peptide produced by endothelial cells. It has been shown to have potent constrictor effects on major arteries in vitro and to raise rat blood pressure in vivo. The present experiments show that endothelin has a potent constrictor action on the microvasculature. Blood flow changes were measured by a xenon clearance technique in rabbit skin. Endothelin, when injected intradermally into rabbit skin, decreased local blood flow in a dose-dependent manner. Endothelin reduced basal skin blood flow and reversed the increased blood flow induced by a vasodilator. These results show that endothelin, administered extravascularly, has potent vasoconstrictor activity. This adds further support to the suggestion that endothelin may have an important role in the physiological control of blood flow and pressure.This publication has 6 references indexed in Scilit:
- A novel potent vasoconstrictor peptide produced by vascular endothelial cellsNature, 1988
- Potent Vasodilator Activity of Calcitonin Gene-Related Peptide in Human SkinJournal of Investigative Dermatology, 1986
- Calcitonin gene-related peptide is a potent vasodilatorNature, 1985
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980
- PROSTAGLANDIN E2, PROSTAGLANDIN I2 AND THE VASCULAR CHANGES OF INFLAMMATIONBritish Journal of Pharmacology, 1979
- Proceedings:Simultaneous measurement of local plasma exudation and blood flow changes induced by intradermal injection of vasoactive substances, using [131I]albumen and 133Xe.1976